Diethyl 2-bromo-5-chloroterephthalate

Catalog No. :
ACXEVM390
CAS No. :
340148-60-9
Molecular Formula :
C12H12BrClO4
Molecular Weight :
335.58

IUPAC Name:Diethyl 2-bromo-5-chloroterephthalate

Diethyl 2-bromo-5-chloroterephthalate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$125.00Login to see priceInquiryInquiry
5g97%$377.00Login to see priceInquiryInquiry
10g97%$567.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameDiethyl 2-bromo-5-chloroterephthalate
IUPAC NameDiethyl 2-bromo-5-chloroterephthalate
Molecular FormulaC12H12BrClO4
Molecular Weight335.58
SMILESO=C(OCC)C1=CC(Cl)=C(C(OCC)=O)C=C1Br
InChI KeyUAEJDZNOMOQBMF-UHFFFAOYSA-N
Synonymdiethyl 2-broMo-5-chloroterephthalate;2-Bromo-5-chloroterephthalic acid diethyl ester;1,4-Benzenedicarboxylic acid, 2-bromo-5-chloro-, 1,4-diethyl ester;Diethyl 2-bromo-5-chlorobenzene-1,4- dicarboxylate;1,4-Diethyl 2-bromo-5-chloro-1,4-benzenedicarboxylate
CAS No.340148-60-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACXEVM390 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXEVM390 route product structure diagram
    ACXEVM390340148-60-9
Inquiry

2. ACXEVM390 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXEVM390 route product structure diagram
    ACXEVM390340148-60-9
Inquiry

Comments (0)